• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载胰岛素和胆酸的玉米醇溶蛋白/酪蛋白-葡聚糖纳米粒增强胰岛素的口服吸收和降血糖作用。

Insulin- and cholic acid-loaded zein/casein-dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin.

机构信息

State Key Laboratory of Molecular Engineering of Polymers, Collaborative Innovation Center of Polymers and Polymer Composite Materials, Department of Macromolecular Science, Fudan University, Shanghai 200438, China.

出版信息

J Mater Chem B. 2021 Aug 21;9(31):6234-6245. doi: 10.1039/d1tb00806d. Epub 2021 Jul 30.

DOI:10.1039/d1tb00806d
PMID:34328161
Abstract

Diabetes mellitus is the most common metabolic disease in the world. Herein, insulin- and cholic acid-loaded zein nanoparticles with dextran surfaces were fabricated to enhance the oral absorptions of insulin in the intestine and in the liver which is the primary action organ of endogenous insulin. In the nanoparticles, zein acted as cement to embed insulin, cholic acid and casein by hydrophobic interactions. The hydrophilic dextran conjugated to casein by the Maillard reaction was located on the nanoparticle surface. The nanoparticles had an insulin loading efficiency of 74.6%, a cholic acid loading efficiency of 55.1% and a hydrodynamic diameter of 267 nm. The dextran significantly increased the disperse stability of the nanoparticles, protected the loaded insulin from hydrolysis in digestive juices, and increased the trans-mucus permeability of the insulin. The embedded cholic acid molecules were consecutively exposed to the surface when the nanoparticles were gradually eroded by proteases. The exposed cholic acid promoted the absorptions of the nanoparticles in the ileum and liver via bile acid transporters. The effect of pretreated lymphatic transport inhibitor cycloheximide revealed that about half of the nanoparticles were transported via the intestinal lymphatic transport pathway and the other half of the nanoparticles were transported via portal blood absorption. The oral pharmacological bioavailability of the nanoparticles in type I diabetic mice was 12.5-20.5%. This study demonstrates that nanoparticles are a promising oral delivery system for insulin.

摘要

糖尿病是世界上最常见的代谢性疾病。本文构建了载胰岛素和胆酸的具有葡聚糖表面的玉米醇溶蛋白纳米粒,以增强胰岛素在肠道和肝脏(内源性胰岛素的主要作用器官)中的口服吸收。在纳米粒中,玉米醇溶蛋白通过疏水相互作用作为水泥将胰岛素、胆酸和酪蛋白嵌入其中。通过美拉德反应与酪蛋白连接的亲水性葡聚糖位于纳米粒表面。纳米粒的胰岛素载药效率为 74.6%,胆酸载药效率为 55.1%,水动力直径为 267nm。葡聚糖显著提高了纳米粒的分散稳定性,保护了载药胰岛素免受消化液的水解,并增加了胰岛素的跨黏膜通透性。当纳米粒被蛋白酶逐渐侵蚀时,嵌入的胆酸分子依次暴露于表面。暴露的胆酸通过胆汁酸转运蛋白促进了纳米粒在回肠和肝脏中的吸收。预处理的淋巴转运抑制剂环己亚胺的作用表明,约一半的纳米粒通过肠淋巴转运途径运输,另一半纳米粒通过门静脉血液吸收运输。在 I 型糖尿病小鼠中的口服药代动力学生物利用度为 12.5-20.5%。本研究表明,纳米粒是胰岛素口服递送的一种有前途的系统。

相似文献

1
Insulin- and cholic acid-loaded zein/casein-dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin.载胰岛素和胆酸的玉米醇溶蛋白/酪蛋白-葡聚糖纳米粒增强胰岛素的口服吸收和降血糖作用。
J Mater Chem B. 2021 Aug 21;9(31):6234-6245. doi: 10.1039/d1tb00806d. Epub 2021 Jul 30.
2
Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice.载有 exenatide 的混合玉米醇溶蛋白纳米粒经口服给药用于 2 型糖尿病小鼠的稳定血糖控制和β细胞修复。
J Nanobiotechnology. 2020 Apr 28;18(1):67. doi: 10.1186/s12951-020-00619-0.
3
Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids.经胆汁酸的肠肝循环实现载胰岛素纳米粒的肝靶向递送。
Drug Deliv. 2018 Nov;25(1):1224-1233. doi: 10.1080/10717544.2018.1469685.
4
A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels.通过胆汁酸转运通道口服给予蛋白质/肽的递药系统。
J Pharm Sci. 2019 Jun;108(6):2143-2152. doi: 10.1016/j.xphs.2019.01.027. Epub 2019 Feb 2.
5
Effective Enhancement of Hypoglycemic Effect of Insulin by Liver-Targeted Nanoparticles Containing Cholic Acid-Modified Chitosan Derivative.含胆酸修饰壳聚糖衍生物的肝靶向纳米颗粒有效增强胰岛素的降血糖作用
Mol Pharm. 2016 Jul 5;13(7):2433-42. doi: 10.1021/acs.molpharmaceut.6b00188. Epub 2016 Jun 17.
6
Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery.通过胆酸预络合和玉米醇溶蛋白/鼠李糖脂纳米复合材料递送促进利拉鲁肽穿透肠上皮细胞。
J Nanobiotechnology. 2023 Jan 16;21(1):16. doi: 10.1186/s12951-022-01743-9.
7
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.高负荷剂量的微囊化格列齐特制剂对1型糖尿病大鼠具有降血糖作用,而加入一种初级去共轭胆汁酸会减弱这种降血糖抗糖尿病作用。
Eur J Drug Metab Pharmacokinet. 2017 Dec;42(6):1005-1011. doi: 10.1007/s13318-017-0415-0.
8
Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.利用载有 LMWP 连接胰岛素缀合物的黏膜黏附纳米粒增强胰岛素口服吸收。
J Control Release. 2016 Jul 10;233:181-90. doi: 10.1016/j.jconrel.2016.05.015. Epub 2016 May 10.
9
Chitosan coating of zein-carboxymethylated short-chain amylose nanocomposites improves oral bioavailability of insulin in vitro and in vivo.壳聚糖包被的玉米醇溶蛋白-羧甲基短链淀粉纳米复合材料提高了胰岛素在体内外的口服生物利用度。
J Control Release. 2019 Nov 10;313:1-13. doi: 10.1016/j.jconrel.2019.10.006. Epub 2019 Oct 14.
10
Fatty acid and quaternary ammonium modified chitosan nanoparticles for insulin delivery.脂肪酸和季铵盐改性壳聚糖纳米粒用于胰岛素传递。
Colloids Surf B Biointerfaces. 2018 Oct 1;170:136-143. doi: 10.1016/j.colsurfb.2018.05.063. Epub 2018 May 30.

引用本文的文献

1
Exploring the Potential of Zein Nanoparticles in Personalised Cancer Therapy, Highlighting Their Various Methodologies, Applications and Challenges.探索玉米醇溶蛋白纳米颗粒在个性化癌症治疗中的潜力,重点介绍其各种方法、应用和挑战。
J Cell Mol Med. 2025 Aug;29(15):e70752. doi: 10.1111/jcmm.70752.
2
Zein-Based Nanocarriers: Advances in Oral Drug Delivery.基于玉米醇溶蛋白的纳米载体:口服给药的进展
Pharmaceutics. 2025 Jul 21;17(7):944. doi: 10.3390/pharmaceutics17070944.
3
Characterization of Taurocholic Acid Binding With Insulin for Potential Oral Formulation Using Different Methods.
采用不同方法对牛磺胆酸与胰岛素结合用于潜在口服制剂的表征。
Electrophoresis. 2025 Apr;46(7-8):468-477. doi: 10.1002/elps.8139. Epub 2025 Apr 16.
4
Drug delivery systems incorporating bile salts: advancements since the conception of bilosomes.包含胆盐的药物递送系统:自双分子层脂质体概念提出以来的进展。
Ther Deliv. 2025 May;16(5):487-500. doi: 10.1080/20415990.2025.2469488. Epub 2025 Mar 24.
5
Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives.用于糖尿病治疗的口服肽疗法:现状与未来展望。
Acta Pharm Sin B. 2024 May;14(5):2006-2025. doi: 10.1016/j.apsb.2024.02.019. Epub 2024 Feb 28.
6
Ceftazidime/Tobramycin Co-Loaded Chitosan-Coated Zein Nanoparticles against Antibiotic-Resistant and Biofilm-Producing and .头孢他啶/妥布霉素共载壳聚糖包被玉米醇溶蛋白纳米粒对抗抗生素耐药及生物膜产生菌和……(原文最后似乎不完整)
Pharmaceuticals (Basel). 2024 Feb 29;17(3):320. doi: 10.3390/ph17030320.
7
Polymeric nanoparticles (PNPs) for oral delivery of insulin.用于胰岛素口服递送的聚合物纳米粒(PNPs)。
J Nanobiotechnology. 2024 Jan 3;22(1):1. doi: 10.1186/s12951-023-02253-y.
8
Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake.核壳型脂质-聚合物杂化纳米粒通过淋巴摄取增强伊布替尼的口服生物利用度。
AAPS PharmSciTech. 2023 Jun 23;24(6):142. doi: 10.1208/s12249-023-02586-9.
9
Zein-based nanoparticles: Preparation, characterization, and pharmaceutical application.基于玉米醇溶蛋白的纳米颗粒:制备、表征及药物应用。
Front Pharmacol. 2023 Feb 1;14:1120251. doi: 10.3389/fphar.2023.1120251. eCollection 2023.
10
Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery.通过胆酸预络合和玉米醇溶蛋白/鼠李糖脂纳米复合材料递送促进利拉鲁肽穿透肠上皮细胞。
J Nanobiotechnology. 2023 Jan 16;21(1):16. doi: 10.1186/s12951-022-01743-9.